Avi A capsule combined with 2% fusidic acid cream in the treatment of moderate to severe acne in 25 cases.docVIP

Avi A capsule combined with 2% fusidic acid cream in the treatment of moderate to severe acne in 25 cases [Abstract] Objective To observe Chae Wei A capsule combined with 2% fusidic acid cream in the treatment of moderate and severe acne. Methods group (n = 25) oral Avi A capsules 10mg, 2 times a day, while lesions at topical 2% fusidic acid cream, night 1, the control group (n = 16) lesions of only 2% fusidic acid topical cream, 1 night, two regimens for 8 weeks. the treatment group The total effective rate was 80.00% in the control group, the total effective rate was 31.25%, the difference was highly significant (2 = 9.74, P lt;0.01). Conclusion Avi A capsule combined with 2% fusidic acid cream in the treatment of satisfactory result of severe acne. [Keywords:] acne unusual Avi A capsule fusidic acid cream Acne is a common chronic inflammatory young follicle sebaceous skin, easy to recurrent long-term diseases, affect the beauty, to bring trouble to the patients .2008 2 months to February 2009, I applied Avi A capsule (trade name: Fang Xi, Chongqing Winbond Pharmaceutical Co., Ltd. Production) Joint 2% fusidic acid cream (Hong Kong, Australian and U.S. pharmaceutical) treatment of 25 patients with moderate to severe acne vulgaris, and achieved satisfactory results, are reported as follows: 1 Materials and Methods 1.1 General Information Author of 41 patients were cases of dermatology out-patient treatment by clinical signs and symptoms consistent with international Improved grading of acne vulgaris [1], moderate to severe acne vulgaris of the diagnostic criteria. 13 males and 28 females, aged 16 to 38 years , duration of 1 month to 8 years. a serious system diseases, pregnancy, breast-feeding women and women planning pregnancy within two years of Victoria A acid allergic to the drug used almost 2 weeks, topical treatment of acne drugs or six months A through D acid within the oral drugs were excluded. by completely randomized design to patients w